NEA Management Company, LLC Q1 2019 Filing
Filed May 8, 2019
Portfolio Value
$1.9T
Holdings
45
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (45 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ESTCELASTIC NV | 5,562,153 | $444.4B | 23.07% | |
| 2 | —RA PHARMACEUTICALS INC | 6,138,797 | $137.5B | 7.14% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $134.6B | 6.99% | |
| 4 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $113.2B | 5.88% | |
| 5 | ALLKGUSDALLAKOS INC | 2,268,188 | $91.9B | 4.77% | |
| 6 | —EPIZYME INC | 6,877,518 | $85.2B | 4.42% | |
| 7 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $75.7B | 3.93% | |
| 8 | CRSPCRISPR THERAPEUTICS AG | 2,090,678 | $74.7B | 3.88% | |
| 9 | —CLEMENTIA PHARMACEUTICALS INC | 2,707,734 | $70.7B | 3.67% | |
| 10 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 15,832,611 | $68.1B | 3.53% | |
| 11 | —MERSANA THERAPEUTICS INC | 11,894,267 | $62.6B | 3.25% | |
| 12 | —OBSEVA SA | 4,586,563 | $58.7B | 3.05% | |
| 13 | —DERMIRA INC | 3,506,649 | $47.5B | 2.47% | |
| 14 | ARDXARDELYX INC | 15,335,047 | $42.9B | 2.23% | |
| 15 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $33.6B | 1.75% | |
| 16 | TPIVDEURMARKER THERAPEUTICS INC | 5,000,000 | $33.0B | 1.71% | |
| 17 | —SYNLOGIC INC | 4,229,410 | $32.1B | 1.67% | |
| 18 | —NIGHTSTAR THERAPEUTICS PLC | 1,214,285 | $30.8B | 1.60% | |
| 19 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $28.3B | 1.47% | |
| 20 | —MILLENDO THERAPEUTICS INC | 1,766,779 | $26.5B | 1.38% | |
| 21 | —AFFIMED NV | 5,138,888 | $21.6B | 1.12% | |
| 22 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $20.6B | 1.07% | |
| 23 | —GENOCEA BIOSCIENCES INC | 34,948,269 | $20.6B | 1.07% | |
| 24 | MEIPUSDMEI PHARMA INC | 5,720,572 | $17.6B | 0.91% | |
| 25 | —AVEO PHARMACEUTICALS INC | 20,896,038 | $17.1B | 0.89% | |
| 26 | SURFUSDSURFACE ONCOLOGY INC | 3,315,149 | $15.8B | 0.82% | |
| 27 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $15.3B | 0.79% | |
| 28 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $13.2B | 0.69% | |
| 29 | BEBLOOM ENERGY CORP | 1,333,333 | $12.2B | 0.63% | |
| 30 | —ARQULE INC | 2,520,316 | $12.1B | 0.63% | |
| 31 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $10.2B | 0.53% | |
| 32 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $8.3B | 0.43% | |
| 33 | VRNAVERONA PHARMA PLC | 1,219,674 | $7.9B | 0.41% | |
| 34 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $7.0B | 0.36% | |
| 35 | —TREVENA INC | 3,811,691 | $5.9B | 0.31% | |
| 36 | ASNSUSDX4 PHARMACEUTICALS INC | 333,333 | $5.8B | 0.30% | |
| 37 | —TRACON PHARMACEUTICALS INC | 3,467,181 | $4.8B | 0.25% | |
| 38 | ERYP1EURERYTECH PHARMA SA | 625,000 | $4.7B | 0.25% | |
| 39 | CTIC1USDCTI BIOPHARMA CORP | 3,750,000 | $3.6B | 0.19% | |
| 40 | —ACHAOGEN INC | 5,215,128 | $2.3B | 0.12% | |
| 41 | —ENDOLOGIX INC | 249,021 | $1.6B | 0.09% | |
| 42 | —AKARI THERAPEUTICS PLC | 452,167 | $1.6B | 0.08% | |
| 43 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $1.6B | 0.08% | |
| 44 | TREURTRILLIUM THERAPEUTICS INC | 2,100,000 | $1.4B | 0.07% | |
| 45 | —REGULUS THERAPEUTICS INC | 915,751 | $934.0M | 0.05% |